abs293.txt	background		cancer	causes	significant	morbidity	and	mortality	among	hiv	patientsin	the	us	due	to	extended	life	expectancy	with	access	effective	antiretroviraltherapy	low	detectable	rna	has	been	studied	as	a	risk	factor	for	adversehealth	outcomes	but	its	clinical	impact	on	remains	unclear	theobjective	of	this	study	was	determine	whether	<1	000	copies/ml	sixmonths	after	starting	therapy	associated	10-year	first	methods	we	followed	7	515	initiators	from	us-based	multicenterclinical	cohort	1998	2014	used	nonparametric	multiple	imputation	toaccount	viral	loads	that	fell	below	assay	detection	limits	categorizedviral	six	months	initiation	into	four	groups	<20	20-199	200-999	>999	calculated	estimates	cumulative	incidenceof	diagnosis	accounting	death	competing	event	inverseprobability	exposure	censoring	weights	were	control	forconfounding	differential	loss	follow	up	respectively	results	crude	in	sample	03%	(95%	ci	6	08%	98%)	highest	observed	patients	loadsbetween	200	999	art	(10	7%)	aftercontrolling	baseline	confounders	90%	(95%ci	5	69%	8	12%)	similar	across	load	categories	conclusion	overall	not	incomplete	viralsuppression	however	threat	aftertreatment	more	gain	treatment	thecurrent	treat	all	era	occurrences	suppression	will	beobserved	frequently	practice	which	supports	continued	ofthe	role	low-level	development
